Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.79% | 171.56 | 1.2% | $575.26m | |
| CELG | Celgene Corporation | -0.75% | 88.95 | 1.2% | $554.24m | |
| GILD | Gilead Sciences, Inc. | -0.99% | 73.70 | 0.9% | $441.10m | |
| BIIB | Biogen Inc. | -1.13% | 263.02 | 1.2% | $436.72m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.50% | 314.25 | 2.7% | $242.24m | |
| INCY | Incyte Corporation | -0.90% | 68.43 | 2.5% | $236.48m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.88% | 158.15 | 1.9% | $224.32m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.54% | 107.78 | 2.0% | $215.70m | |
| NKTR | Nektar Therapeutics | -4.37% | 86.21 | 6.0% | $196.49m | |
| ILMN | Illumina, Inc. | -0.50% | 244.60 | 3.5% | $185.23m | |
| A | Agilent Technologies, Inc. | -0.63% | 67.54 | 1.5% | $152.87m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.34% | 97.48 | 9.8% | $137.98m | |
| BLUE | Bluebird Bio, Inc. | 0.00% | 170.50 | 15.8% | $135.45m | |
| EXAS | Exact Sciences Corporation | 1.54% | 47.52 | 25.7% | $108.85m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.58% | 82.30 | 4.4% | $107.66m |
Company Profile
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It also offers programs in clinical development for diabetes, irritable bowel syndrome, and carcinoid syndrome. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.